VIDO-InterVac is acting as a service provider to groups developing vaccine, antiviral, and other therapeutics against for COVID-19. This includes:
In vitro testing:
Assessing compounds against SARS-CoV-2 using in vitro culture systems.
In vivo testing:
We have an established SARS-CoV-2 challenge model in ferrets to test the efficacy of vaccines and other therapeutics. We are establishing a golden hamster model.
VIDO-InterVac operates with an approved ISO 9001 quality management system. All COVID-19 projects are managed by a dedicated project manager and are completed by our multidisciplinary research team using our containment level 3 facility.Contact Us